SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is trending as its community fervently debates and anticipates a potential S&P 500 inclusion, which has sharply divided sentiment between expectations of a significant rally and fears of a decline, amidst broader market volatility.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as news circulates about the departure of a key FDA official, which the community believes removes a significant hurdle and could accelerate the approval path for their Duchenne Muscular Dystrophy (DMD) therapy, Deramiocel; this development, combined with upcoming Phase 3 data presentations, is intensifying short squeeze and buyout speculation.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure is surging as a key FDA official's departure and reports of a less invasive trial design for its Huntington's gene therapy ignite community hopes for accelerated approval, triggering a significant short squeeze after a week of regulatory setbacks.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings (LITE) is trending amid its S&P 500 inclusion and a significant strategic investment from NVIDIA, solidifying its critical position in AI infrastructure expansion. The community is actively discussing whether its high valuation is justified by its role in supplying advanced optical components, particularly in light of industry perspectives on optical versus copper solutions for data center connectivity.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. It also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment offers products and services sold for applications within the data center, communication networks, and commercial and industrial markets in North America and Latin America. The Asia Pacific segment includes products and services sold for applications within the data center, communication networks, and commercial or industrial markets throughout Greater China, Australia and New Zealand, Southeast Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Columbus, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertiv Holdings Co. (VRT) is a major talking point among investors after its announcement to join the S&P 500 index on 3/23, leading to widespread discussion around anticipated 'inclusion play' gains and the implications of forced buying by index funds.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending as CEO Doug Ingram's upcoming retirement, prompted by a personal family health challenge, sparks community discussion about potential M&A and a fresh leadership direction. This, coupled with optimism over a potentially evolving FDA regulatory landscape and anticipation for new siRNA pipeline data, fuels talks of the company's significant undervaluation and short-squeeze potential.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

With upcoming clinical data readouts and potential international approvals for its personalized TIL therapy, Iovance Biotherapeutics is showing exceptional relative strength in a weak market, sparking community speculation of a significant short squeeze and potential buyout.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is surging as escalating conflict with Iran significantly disrupts oil traffic through the vital Strait of Hormuz, driving the biggest weekly crude gains in decades. The community is actively debating whether this is a genuine physical supply squeeze or fear-driven, with many expecting oil to climb well past $100 as regional producers face storage limits.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is trending as its fortified balance sheet, recent defense contract wins, U.S. Army qualification, and a new CEO compensation plan tied to aggressive valuation milestones spark intense community debate, balancing optimism for its critical role in aerospace and defense against concerns over institutional exits, high short interest, and potential dilution.

Coherent Corp. engages in the development, refinement, manufacturing, and marketing of engineered materials, opto-electronic components and devices, and lasers for use in the industrial, communications, electronics, and instrumentation markets. It operates through the following segments: Networking, Materials, and Lasers. The Networking segment leverages compound semiconductor technology platforms and deep knowledge of end-user applications. The Materials segment markets engineered materials and optoelectronic devices. The Lasers segment serves industrial customers in semiconductor capital equipment, display capital equipment, precision manufacturing, and aerospace and defense, as well as instrumentation customers in life sciences and scientific research. The company was founded by Carl J. Johnson in 1971 and is headquartered in Saxonburg, PA.

Coherent Corp

NVIDIA's substantial investment and strategic partnership for optical interconnects has put Coherent at the forefront of the AI infrastructure conversation, with investors also discussing its recent S&P 500 inclusion as a key sector player.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

180 Life Sciences Corp, which is rebranding as ETHZilla, drew heavy retail interest on Tuesday after revealing that it holds $349 million worth of Ethereum and about $238 million in cash equivalents, alongside a recent 7.5% stake disclosure from billionaire investor Peter Thiel.The stock more than tripled to $6.9 on Tuesday, hitting a 10-month high, and added another 6.7% in after-hours trading.The company stated that it owns 82,186 Ether (ETH) at an average purchase price of $3,806.71, with recent acquisitions intended for long-term holding and staking through Electric Capital’s proprietary strategies, which aim to generate yield.&nbsp;Executive Chairman McAndrew Rudisill said more than $350 million had been deployed since closing a $425 million private investment in public equity (PIPE) deal last week.ETHZilla’s treasury strategy is based on plans announced on July 29 to make Ether its principal reserve asset, managed through an on-chain yield generation program designed to outperform traditional ETH staking.&nbsp;The PIPE deal drew more than 60 institutional and crypto-native investors, including Electric Capital, Polychain Capital, GSR, and Ethereum ecosystem founders such as Konstantin Lomashuk, Sreeram Kannan, and Robert Leshner.The Palo Alto-based company said its DeFi Council, comprising capital markets veterans, engineers, and protocol founders, will advise on strategies that combine staking, lending, liquidity provision, and private agreements.&nbsp;ETHZilla stated that it aims to establish itself as a benchmark for on-chain treasury management among public companies.In a regulatory filing with the U.S. Securities and Exchange Commission&nbsp;late Monday, Thiel reported beneficial ownership of 11.6 million shares, or 7.5% of ETHZilla, through entities linked to his Founders Fund.Originally a biotechnology company, 180 Life Sciences is shifting toward Ethereum-focused treasury management, software-enabled gaming, and entertainment, while seeking to monetize its legacy biotech assets.On Stocktwits, retail sentiment was ‘extremely bullish’ amid a 2,363% surge in 24-hour message volume.One user noted that traders who bought $ATNF warrants had seen outsized gains, attributing the rally largely to Ethereum’s strength and calling crypto treasury plays “hot” across multiple tickers.<stembedurl>https://stocktwits.com/CCTVon/message/624880257</stembedurl>Another user pointed out that $ATNF was now another Ethereum treasury company with backing from Peter Thiel, who had also invested in $BMNR, and said they planned to take a position.<stembedurl>https://stocktwits.com/moonstocks777/message/624875436</stembedurl>180 Life Sciences’ stock has risen nearly 463% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration of the ethereum cryptocurrency 'altcoin' sits arranged for a photograph on April 25, 2018 in London, England. (Photo by Jack Taylor/Getty Images)

This Small-Cap Life Sciences Stock More Than Tripled, Thanks To An Ethereum Pivot And Peter Thiel

180 Life Sciences, set to rebrand as ETHZilla, revealed a $349 million Ethereum reserve, a staking plan with Electric Capital, and a 7.5% stake from Peter Thiel’s Founders Fund.

Equity

180 Life Sciences (ATNF) 180 Life Sciences surged more than 500% on Wednesday becoming the top gainer across U.S. exchanges, boosting retail sentiment.The <a href="https://stocktwits.com/news-articles/markets/equity/atnf-stock-surges-on-online-gaming-pivot/cJcz40JRIG">sharp rally</a> followed the company’s announcement of its strategic pivot into online gaming, or iGaming, a move that seems to have sent retail investors into a frenzy.Retail sentiment on Stocktwits has skyrocketed to ‘extremely bullish’ (97/100) from ‘neutral’ a day ago.<img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_16_223155_cd82ae123f.png" alt="Screenshot 2024-10-16 223155.png">NuScale Power Corp. (SMR)NuScale Power shares surged 33% on Wednesday, buoyed by <a href="https://stocktwits.com/news-articles/markets/equity/amazon-signs-agreements-to-support-nuclear-energy-development/cJcza0dRIc">Amazon's decision</a> to invest in nuclear energy to power its data centers and other facilities at its Washington state headquarters.NuScale specializes in small modular reactors (SMRs), the same cutting-edge technology Amazon is considering to meet its growing energy demands. The stock soared to an all-time high of $18.01, marking a remarkable 473% year-to-date increase.Retail sentiment on Stocktwits has dramatically shifted, moving from 'bearish' to 'extremely bullish' (97/100) within a day.<img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_16_225310_41cad3a0dc.png" alt="Screenshot 2024-10-16 225310.png">Korro Bio (KRRO)Korro Bio's shares skyrocketed 111% on Wednesday following Wave Life Sciences’ <a href="https://stocktwits.com/news-articles/markets/equity/wave-life-sciences-stock-surges-on-rna-editing-breakthrough/cJczOOPRI5">announcement</a> of early validation for its latest RNA editing technology, a promising breakthrough in the field of genetic medicine.Korro Bio is heavily investing in RNA editing therapies, specifically targeting Alpha-1 Antitrypsin Deficiency (AATD). The company plans to seek regulatory approval by the end of the year to begin clinical trials for its RNA editing treatments.Retail sentiment around the company on Stocktwits has been initiated at ‘extremely bullish’ (97/100).<img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_16_231152_5247ea7ca2.png" alt="Screenshot 2024-10-16 231152.png">For updates and corrections email newsroom@stocktwits.com.Read more:<a href="https://stocktwits.com/news-articles/markets/equity/tsla-stock-falls-after-robotaxi-event-underwhelms/cJcVcLcR4T">&nbsp;</a><a href="https://stocktwits.com/news-articles/markets/equity/abbott-labs-stock-dips-pre-market-on-narrowed-profit-outlook-retail-turns-bearish/cJcz2u7R4D">Abbott Labs Stock Dips Pre-Market On Narrowed Profit Outlook: Retail Turns Bearish</a>

Rising stock prices of 180 Life Sciences, Korro Bio, and NuScale Power fuel bullish retail sentiment on Stocktwits

180 Life Sciences, Korro Bio, NuScale Power: Retail Investors Turn Most Bullish On These Stocks

Small-cap stocks like Korro Bio and NuScale Power are benefiting from the momentum generated by larger stocks.

Shares of 180 Life Sciences Corp. (<a class="mention" data-mention="$ATNF" data-symbol-id="ATNF" href="https://stocktwits.com/symbol/ATNF" target="_blank">$ATNF</a>) surged more than 500% on Wednesday, becoming the top gainer across U.S. exchanges, boosting retail sentiment.The sharp rally followed the company’s announcement of its strategic pivot into online gaming, or iGaming, a move that has sent retail investors into a frenzy.In a letter to shareholders, interim CEO Blair Jordan revealed that 180 Life Sciences plans to enter the global iGaming market using a newly acquired blockchain-based gaming platform, which supports cryptocurrency transactions.Initially, the company will focus on B2C online casinos, with plans to expand into a B2B model that will provide blockchain-enabled technology solutions to gaming operators worldwide.180 Life highlighted that it sees attractive acquisition opportunities within the iGaming industry, leveraging the company’s Nasdaq listing to consolidate private gaming firms.“We hope that this liquidity advantage will allow 180 to acquire private gaming companies at attractive valuations,” the company stated, though no immediate acquisitions are planned as it continues conducting preliminary diligence.<figure class="image"><a href="https://stocktwits.com/symbol/ATNF"><img style="aspect-ratio:1314/320;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/ATNF_sentiment_and_message_volume_Oct_16_2024_910b66e22e.png" alt="ATNF sentiment and message volume Oct 16 2024.png" width="1314" height="320"></a><figcaption>ATNF sentiment and message volume Oct 16 2024 as of 10:45 am ET | source: Stocktwits</figcaption></figure>Retail investors responded enthusiastically on Stocktwits, where sentiment shifted to ‘extremely bullish’ (97/100) from ‘neutral’ just a day prior.<stembedurl>https://stocktwits.com/JJ353/message/589101640</stembedurl><stembedurl>https://stocktwits.com/evanevans/message/589087909</stembedurl>180 Life Sciences confirmed last week that it had regained compliance with Nasdaq’s minimum stockholders’ equity requirement, a crucial step that enables it to focus on its iGaming expansion while continuing to advance its biotechnology programs.Earlier this month, the company reported progress on its synthetic CBD analogs (SCAs), designed as safer, more effective alternatives to unregulated CBD products.Year-to-date, the stock is up more than 165%. The company's current market cap is under a million dollars.Read next: <a href="https://stocktwits.com/news-articles/markets/equity/nvax-stock-falls-after-fda-clinical-hold-on-vaccine-candidates/cJczdHnR4y">Novavax Stock Tanks After FDA’s Clinical Hold On Vaccine Candidates: Retail Turns Jittery</a> &nbsp;

These stocks hit a new 52-week high today

180 Life Sciences Turns Retail Heads With Online Gaming Entry, Stock Surges 500% 

Interim CEO Blair Jordan revealed that 180 Life Sciences plans to enter the global iGaming market using a newly acquired blockchain-based gaming platform, which supports cryptocurrency transactions.

Forum Markets, Inc. is a technology company in the decentralized finance (DeFi) industry, which intends to connect financial institutions, businesses, and organizations worldwide by enabling secure, accessible blockchain transactions through Ethereum Network protocol implementations. It continues to maintain the deployment and development of its biotech and gaming operations. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palm Beach, FL.

Current Price	$2.89
Prev Close	$3.00
Open	$2.88
Dividend Yield	0.00%
50-Day Moving Average	$4.35
Beta	1.33
Avg. Volume	603,803.63
PE Ratio	-0.05

52-Week High	$174.60
52-Week Low	$2.91
Market Capitalization	$58.97M
EPS (Annual)	-$154.91
Price to Book	0.11
Revenue Per Employee	$0.00

ATNF
180 Life Sciences Corp

Feed

News

Sentiment

Fundamentals

Info

Latest ATNF News

ATNF180 Life Sciences Corp